Welcome - Home - Register - Login - Help/FAQ - 0 items

Search Enter keywords, a title or a report id number below. In All Categories --------------------- Telecom & Computing Business & Finance Mfg & Construction Pharma & Healthcare Consumer & Retail Gov & Public Sector Energy & Transport Country Reports Company Reports --------------------- Transcripts Advanced      Select a currency for use throughout the site Australia Dollars Canada Dollars Euro Japan Yen Sweden Kroner Switzerland Francs UK Pounds US Dollars Viewing report Order by Fax Printer Friendly PDF Brochure Send to Friend Enquire before Buying Hard Copy Electronic Site License Strategic Perspective 2001: Female Cancers - Optimizing Market Opportunities Datamonitor, May 2001   Description     Table of Contents        Enquire before Buying    Send to a Friend   The paucity of available clinical trial data for most gynecological cancers means that gold standard treatments have not been universally established. Many drugs indicated for the treatment of tumors with high incidence are also efficacious in gynecological tumors with lower incidence. How can the market opportunities in these niche cancers be exploited? Strategic Perspectives 2001: Female Cancers covers breast cancer and seven gynecological cancers (cervical, ovarian, endometrial, vulvar, vaginal, gestational trophoblastic disease and uterine sarcoma). The report provides an in-depth evaluation of female cancer epidemiology, current market dynamics, recommended company strategies and major pipeline products and forecasts the performance of female cancer drugs to 2008. Customers who bought this item also bought Side Effects of Male Cancers - Better Survival and Growing Social Acceptance of Impotence and Urinary Incontinence Equates to New Opportunities for Drug Therapies Angiogenesis Inhibitors 2001 - State-of-the-Science and Strategic Opportunities Niche Cancers 2001: Glioblastoma Chemotherapy Market Insights, 2006-2016: A Critical Analysis of Cancer Research, Treatments, Pipelines, and Commercial Opportunities 25+ Business Development and Innovation Opportunities in Cancer Medicine - 2001 Niche Cancers 2001: Head and Neck Cancer Strategic Perspectives 2001: Cancer Patient Power - Partnering With a New Generation of Cancer Consumers Colony Stimulating Factors State-of-the-Science and Strategic Opportunities

		Top of page

All rights reserved. � Copyright 2008 Research and Markets    Terms and conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster